GlassScriptPhysician profile
John O Bannon
NPI 1720059900
$6,682.34
in general payments reported to CMS, 2019-2025
52 companies · $42.28 in 2025
The $42.28 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,059 · 2020: $756 · 2021: $1,546 · 2022: $1,555 · 2023: $663 · 2024: $60.21 · 2025: $42.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $683.09 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $622.69 | 2019-2023 | Soliris |
| Biogen, INC. | $604.57 | 2019-2023 | Tysabri, Vumerity |
| Novartis Pharmaceuticals Corporation | $544.37 | 2019-2025 | |
| Amgen INC. | $423.46 | 2019-2021 | |
| Emd Serono, INC. | $386.66 | 2019-2022 | |
| Ucb, INC. | $336.03 | 2019-2023 | Briviact |
| Biohaven Pharmaceuticals, INC. | $327.56 | 2020-2021 | |
| Genzyme Corporation | $276.50 | 2019-2022 | |
| Kyowa Kirin, INC. | $179.86 | 2020-2023 | Nourianz |
| Lundbeck LLC | $177.83 | 2019-2023 | Vyepti |
| Mdd US Operations, LLC | $155.43 | 2019-2024 | Gocovri, Gocovri |
| Sunovion Pharmaceuticals INC. | $152.43 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $135.39 | 2019-2023 | Rytary |
| Genentech USA, INC. | $113.84 | 2019-2023 | Ocrevus |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John O Bannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.